Post-approval studies (Phase 4)Study completedNCT00139581
What this trial is testing
Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects
Who this might be right for
Atopic Dermatitis
Novartis